Medical Company Announces Crucial Program Expansion For Breast Cancer

Processa Pharmaceuticals Expands NGC-Cap Program into Advanced or Metastatic Breast Cancer: What You Need to Know.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an important development for the medical and pharmaceutical industry, Processa Pharmaceuticals Inc. has announced its plans to expand the NGC-Cap program into advanced or metastatic breast cancer. This deve…